Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial)

Authors:

Abstract
No abstract available

This publication has 22 references indexed in Scilit: